8:53pm

US doctors paid $1bn by drug companies

Data reveal spending for entertainment, consulting and research

May 21, 2013

Cash-to-doctors data reflect rivalries

Research shows nearly a quarter of payments went to two specialisms

From UK May 21, 2013

NHS wasted £74m on Tamiflu, says watchdog

Criticism comes at a time of growing scrutiny on use of the drug

Actavis medicine ©Getty From LEX May 20, 2013

Actavis / Warner Chilcott: simple medicine

The $8.5bn deal lacks flash, but the price is right

May 20, 2013

Elan steps up fight against Royalty bid

Irish group announces fresh debt and acquisition plans

May 20, 2013

Actavis to buy Warner Chilcott for $5bn

All-stock deal could end series of merger talks

From UK May 20, 2013

FTSE 100 groups expect fall in tax cases

Appetite for conflict appears to be waning

May 19, 2013

Small-cap week, May 18

Electrocomponents, Jarden and Green Dragon Gas featured

Angelina Joile ©Getty Christopher Caldwell from COMMENT May 17, 2013

The dilemmas of genetic screening

Some awkward questions arise with new medical technology

From PERSONAL FINANCE May 17, 2013

Directors’ Deals: latest trades

Round-up of boardroom trading

May 16, 2013

Elan rejects Royal Pharma’s $5.7bn bid

Irish pharma group rejects PE firm’s offer

From UK May 15, 2013

Former Nice chief’s new job stirs concern

Appointment raises concern over potential conflict of interest

From WORLD May 15, 2013

Malaria-infected mosquitos drawn to humans

Work could help boost efforts to eliminate disease

From COMMENT May 15, 2013

India: Patents and precedents

Pharmaceutical companies fear that the battle raging in India over patents will inspire other countries to change their laws

From TECHNOLOGY May 15, 2013

Scientists make human cloning breakthrough

Caffeine proves to be vital ingredient in procedure

May 14, 2013

E-Therapeutics ‘encouraged’ by drug trial

Company hopes to have licensing deal on ETS2101 by 2017

Business Blog from WORLD May 14, 2013

Business blog: Just when you thought it was safe...

The Short View from MARKETS May 13, 2013

Beware side-effects of biotech boom

Scale of rally suggests caution is warranted

May 13, 2013

Elan makes $1bn Theravance investment

Irish drugs group seeks to weaken Royalty Pharma’s hostile bid

From LEX May 13, 2013

Elan: two can play

Drugs company is turning itself into a bigger version of its stalker

COMPANIES NEWS ON TWITTER

More FT Twitter accounts